Publications

Detailed Information

VEGF and Ki-67 overexpression in predicting poor overall survival in adenoid cystic carcinoma

DC Field Value Language
dc.contributor.authorPark, Seongyeol-
dc.contributor.authorNam, Soo Jeong-
dc.contributor.authorKeam, Bhumsuk-
dc.contributor.authorKim, Tae Min-
dc.contributor.authorJeon, Yoon Kyung-
dc.contributor.authorLee, Se-Noon-
dc.contributor.authorHah, J. Hun-
dc.contributor.authorKwon, Tack-Kyun-
dc.contributor.authorKim, Dong-Wan-
dc.contributor.authorSung, Myung-Whun-
dc.contributor.authorHeo, Dae Seog-
dc.contributor.authorBang, Yung-Jue-
dc.date.accessioned2020-04-27T11:16:29Z-
dc.date.available2020-04-27T11:16:29Z-
dc.date.created2018-08-27-
dc.date.issued2016-04-
dc.identifier.citationCancer Research and Treatment, Vol.48 No.2, pp.518-526-
dc.identifier.issn1598-2998-
dc.identifier.other46945-
dc.identifier.urihttps://hdl.handle.net/10371/165326-
dc.description.abstractPurpose The purpose of this study was to evaluate potential prognostic factors in patients with adenoid cystic carcinoma (ACC). Materials and Methods A total of 68 patients who underwent curative surgery and had available tissue were enrolled in this study. Their medical records and pathologic slides were reviewed and immunohistochemistry for basic fibroblast growth factor, fibroblast growth factor receptor (FGFR) FGFR3, c-kit, Myb proto-oncogene protein, platelet-derived growth factor receptor beta, vascular endothelial growth factor (VEGF), and Ki-67 was performed. Univariate and multivariate analysis was performed for determination of disease-free survival (DFS) and overall survival (OS). Results In univariate analyses, primary site of nasal cavity and paranasal sinus (p=0.022) and Ki-67 expression of more than 7% (p=0.001) were statistically significant factors for poor DFS. Regarding OS, perineural invasion (p=0.032), high expression of VEGF (p=0.033), and high expression of Ki-67 (p=0.007) were poor prognostic factors. In multivariate analyses, primary site of nasal cavity and paranasal sinus (p=0.028) and high expression of Ki-67 (p=0.004) were independent risk factors for poor DFS, and high expression of VEGF (p=0.011) and Ki-67 (p=0.011) showed independent association with poor OS. Conclusion High expression of VEGF and Ki-67 were independent poor prognostic factors for OS in ACC.-
dc.language영어-
dc.publisher대한암학회-
dc.titleVEGF and Ki-67 overexpression in predicting poor overall survival in adenoid cystic carcinoma-
dc.typeArticle-
dc.contributor.AlternativeAuthor방영주-
dc.identifier.doi10.4143/crt.2015.093-
dc.citation.journaltitleCancer Research and Treatment-
dc.identifier.wosid000374197200011-
dc.identifier.scopusid2-s2.0-84963930493-
dc.citation.endpage526-
dc.citation.number2-
dc.citation.startpage518-
dc.citation.volume48-
dc.identifier.sci000374197200011-
dc.identifier.kciidART002099157-
dc.description.isOpenAccessY-
dc.contributor.affiliatedAuthorJeon, Yoon Kyung-
dc.contributor.affiliatedAuthorHah, J. Hun-
dc.contributor.affiliatedAuthorKwon, Tack-Kyun-
dc.contributor.affiliatedAuthorKim, Dong-Wan-
dc.contributor.affiliatedAuthorSung, Myung-Whun-
dc.contributor.affiliatedAuthorHeo, Dae Seog-
dc.contributor.affiliatedAuthorBang, Yung-Jue-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.subject.keywordPlusSALIVARY-GLAND CARCINOMAS-
dc.subject.keywordPlusDISTANT METASTASIS-
dc.subject.keywordPlusBREAST-CANCER-
dc.subject.keywordPlusGROWTH-FACTOR-
dc.subject.keywordPlusC-KIT-
dc.subject.keywordPlusEXPRESSION-
dc.subject.keywordPlusPROGNOSIS-
dc.subject.keywordPlusNECK-
dc.subject.keywordPlusHEAD-
dc.subject.keywordPlusINVASION-
dc.subject.keywordAuthorAdenoid cystic carcinoma-
dc.subject.keywordAuthorImmunohistochemistry-
dc.subject.keywordAuthorVascular endothelial growth factor-
dc.subject.keywordAuthorKi-67-
dc.subject.keywordAuthorPrognosis-
Appears in Collections:
Files in This Item:

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area Clinical Medicine

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share